癌症诊断与治疗中的生物病理标志物
Bio-Pathological Markers in the Diagnosis and Therapy of Cancer.
作者信息
Broggi Giuseppe, Salvatorelli Lucia
机构信息
Department G.F. Ingrassia, Azienda Ospedaliero-Universitaria "Policlinico-Vittorio Emanuele", Anatomic Pathology, University of Catania, 95 125 Catania, Italy.
出版信息
Cancers (Basel). 2020 Oct 25;12(11):3113. doi: 10.3390/cancers12113113.
Abstract
The two medical sciences that mostly deal with the diagnostic approach to human neoplasms in clinical practice are undoubtedly radiology and pathology [...].
摘要
在临床实践中，主要涉及人类肿瘤诊断方法的两门医学学科无疑是放射学和病理学[...]。
相似文献
1
Bio-Pathological Markers in the Diagnosis and Therapy of Cancer.癌症诊断与治疗中的生物病理标志物
Cancers (Basel). 2020 Oct 25;12(11):3113. doi: 10.3390/cancers12113113.
2
Editorial: Bio-Pathological Markers in the Diagnosis and Therapy of Cancer.社论：癌症诊断与治疗中的生物病理标志物
Cancers (Basel). 2023 Feb 26;15(5):1484. doi: 10.3390/cancers15051484.
3
Practice guidelines for the pathological diagnosis of primary liver cancer: 2015 update.原发性肝癌病理诊断实践指南：2015年更新版
World J Gastroenterol. 2016 Nov 14;22(42):9279-9287. doi: 10.3748/wjg.v22.i42.9279.
4
How to assess the best immunohistochemical panel in the diagnosis of malignant pleural mesothelioma in a pathology lab.如何在病理实验室评估用于诊断恶性胸膜间皮瘤的最佳免疫组织化学检测组合。
J Immunoassay Immunochem. 2018;39(3):263-273. doi: 10.1080/15321819.2018.1472606. Epub 2018 May 14.
5
Value of topoisomerase II alpha, MIB-1, p53, E-cadherin, retinoblastoma gene protein product, and HER-2/neu immunohistochemical expression for the prediction of biologic behavior in adrenocortical neoplasms.拓扑异构酶IIα、MIB-1、p53、E-钙黏蛋白、视网膜母细胞瘤基因蛋白产物及HER-2/neu免疫组化表达对肾上腺皮质肿瘤生物学行为预测的价值
Appl Immunohistochem Mol Morphol. 2001 Sep;9(3):215-21. doi: 10.1097/00129039-200109000-00004.
6
Application of immunohistochemistry in gastrointestinal and liver neoplasms: new markers and evolving practice.免疫组织化学在胃肠道和肝脏肿瘤中的应用：新标志物与不断发展的实践
Arch Pathol Lab Med. 2015 Jan;139(1):14-23. doi: 10.5858/arpa.2014-0153-RA.
7
The pathological and molecular diagnosis of malignant pleural mesothelioma: a literature review.恶性胸膜间皮瘤的病理与分子诊断：文献综述
J Thorac Dis. 2018 Jan;10(Suppl 2):S276-S284. doi: 10.21037/jtd.2017.10.125.
8
Soft tissue tumor pathology: New diagnostic immunohistochemical markers.软组织肿瘤病理学：新的诊断性免疫组化标志物
Semin Diagn Pathol. 2015 Sep;32(5):370-80. doi: 10.1053/j.semdp.2015.02.012. Epub 2015 Feb 4.
9
Molecular Pathology: Predictive, Prognostic, and Diagnostic Markers in Uterine Tumors.分子病理学：子宫肿瘤中的预测性、预后性和诊断性标志物
Surg Pathol Clin. 2016 Sep;9(3):405-26. doi: 10.1016/j.path.2016.04.006.
10
Predictive markers in bladder cancer: do we have molecular markers ready for clinical use?膀胱癌的预测标志物：我们是否有准备好用于临床的分子标志物？
Crit Rev Clin Lab Sci. 2014 Oct;51(5):291-304. doi: 10.3109/10408363.2014.930412. Epub 2014 Jul 18.
引用本文的文献
1
The impact of mammographic breast density on locoregional recurrence in breast cancer: a systematic review and meta-analysis.乳腺钼靶密度对乳腺癌局部区域复发的影响：一项系统评价和荟萃分析。
Breast Cancer Res Treat. 2025 Aug 25. doi: 10.1007/s10549-025-07804-5.
2
Editorial: Bio-Pathological Markers in the Diagnosis and Therapy of Cancer.社论：癌症诊断与治疗中的生物病理标志物
Cancers (Basel). 2023 Feb 26;15(5):1484. doi: 10.3390/cancers15051484.
3
Overview of MicroRNAs as Diagnostic and Prognostic Biomarkers for High-Incidence Cancers in 2021.2021 年高发性癌症的 microRNAs 作为诊断和预后生物标志物概述。
Int J Mol Sci. 2022 Sep 27;23(19):11389. doi: 10.3390/ijms231911389.
4
Diagnostic Utility of the Immunohistochemical Expression of Serine and Arginine Rich Splicing Factor 1 (SRSF1) in the Differential Diagnosis of Adult Gliomas.富含丝氨酸和精氨酸剪接因子1（SRSF1）免疫组化表达在成人胶质瘤鉴别诊断中的诊断效用
Cancers (Basel). 2021 Apr 26;13(9):2086. doi: 10.3390/cancers13092086.
本文引用的文献
1
Programmed death-1 or programmed death ligand-1 inhibitors? A meta-analysis of differential efficacy as compared to chemotherapy in advanced non-small cell lung cancer.程序性死亡受体-1 或程序性死亡配体-1 抑制剂？与化疗相比在晚期非小细胞肺癌中疗效差异的荟萃分析。
J Oncol Pharm Pract. 2021 Mar;27(2):405-413. doi: 10.1177/1078155220964903. Epub 2020 Oct 12.
2
MacroH2A1 Immunoexpression in Breast Cancer.MacroH2A1在乳腺癌中的免疫表达
Front Oncol. 2020 Aug 21;10:1519. doi: 10.3389/fonc.2020.01519. eCollection 2020.
3
Immunohistochemistry Innovations for Diagnosis and Tissue-Based Biomarker Detection.免疫组织化学创新在诊断和组织生物标志物检测中的应用。
Curr Hematol Malig Rep. 2019 Oct;14(5):368-375. doi: 10.1007/s11899-019-00533-9.
4
Immunoexpression of SPANX-C in metastatic uveal melanoma.SPANX-C 在转移性葡萄膜黑色素瘤中的免疫表达。
Pathol Res Pract. 2019 Jul;215(7):152431. doi: 10.1016/j.prp.2019.04.023. Epub 2019 Apr 29.
5
MGMT promoter methylation status testing to guide therapy for glioblastoma: refining the approach based on emerging evidence and current challenges.MGMT 启动子甲基化状态检测指导胶质母细胞瘤的治疗：基于新出现的证据和当前的挑战来改进方法。
Neuro Oncol. 2019 Feb 14;21(2):167-178. doi: 10.1093/neuonc/noy132.
6
STAT6 expression in spindle cell lesions of the breast: An immunohistochemical study of 48 cases.乳腺梭形细胞病变中STAT6的表达：48例病例的免疫组织化学研究
Pathol Res Pract. 2018 Oct;214(10):1544-1549. doi: 10.1016/j.prp.2018.07.011. Epub 2018 Jul 17.
7
Primary brain tumours in adults.成人原发性脑肿瘤。
Lancet. 2018 Aug 4;392(10145):432-446. doi: 10.1016/S0140-6736(18)30990-5. Epub 2018 Jul 27.
8
Characterization of invisible breast cancers in digital mammography and tomosynthesis: radio-pathological correlation.数字化乳腺钼靶摄影和断层合成中隐匿性乳腺癌的特征：放射病理学相关性
Radiologia. 2017 Nov-Dec;59(6):511-515. doi: 10.1016/j.rx.2017.08.002. Epub 2017 Sep 22.
9
Uveal Melanoma Nuclear BRCA1-Associated Protein-1 Immunoreactivity Is an Indicator of Metastasis.葡萄膜黑色素瘤核 BRCA1 相关蛋白-1 免疫反应性是转移的指标。
Ophthalmology. 2018 Feb;125(2):203-209. doi: 10.1016/j.ophtha.2017.07.018. Epub 2017 Aug 18.
10
ADAM 10 expression in primary uveal melanoma as prognostic factor for risk of metastasis.原代葡萄膜黑色素瘤中ADAM 10的表达作为转移风险的预后因素
Pathol Res Pract. 2016 Nov;212(11):980-987. doi: 10.1016/j.prp.2016.08.003. Epub 2016 Aug 9.
Zotero 插件